We are a biotechnology company dedicated to developing next-generation therapeutics to improve the lives of patients with severe and life-altering brain diseases. Bright Minds’ broad portfolio of new chemical entities (NCEs) are positioned to treat a variety of pain indications, seizures, and neuropsychiatric disorders.
/image%2F6304363%2F20210323%2Fob_3371c3_bigstock-stock.jpg)
Addiction to SSRIs is what mental health patients, as well as psychologists, despise. That’s when none of these two parties know how to proceed with the treatment exactly. With numerous nerves just in the central nervous system, many things can go wrong...
/image%2F6304363%2F20210218%2Fob_315e03_drugdeveloper-brightminds.jpg)
Dysfunction in the serotonergic circuit of the brain is the root cause of a lot of psychiatric and neurological illnesses. This means, if serotonin (5-HT) is regulated, it can resolve a lot of brain health issues. Bright Minds Biosciences is the only...
/image%2F6304363%2F20210217%2Fob_99722f_epilepsy.jpg)
By levering out the in house expertise in neuroscience and mental health, Bright Minds BioScience is developing the rapid-acting drugs that have already transformed the way in which mental health issues are addressed.
/image%2F6304363%2F20210213%2Fob_dd5d6c_brain-4490831-1280.jpg)
The lead scientist at our biotechnology company has already successfully provided the world with a viable solution for curing Alzheimer’s. By putting together an excellent team of organic chemists, drug designers, research scientists, behavioral biologists,...
